Pyxis Oncology
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
-0.83-0.90-0.70-0.58
Price/Sales ratio
98.296.292.110.84
Earnings per Share (EPS)
$-1.43$-1.32$-1.70$-2.05

Historical Multiples (2019 – 2023)

2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-169.93-35.48-4.33-0.37-0.97-2.12-19.91
Price/Sales ratio
N/AN/AN/AN/AN/AN/AN/A
Price/Book Value ratio
-157.57-28.941.350.270.570.781.06
Price/Cash Flow ratio
-202.26-44.91-10.00-0.49-1.01-0.89-27.45
Price/Free Cash Flow ratio
-202.26-39.15-9.85-0.46-0.92-0.85-24.50
Price/Earnings Growth ratio
N/A-0.09-0.00-0.000.02-0.01-0.00
Dividend Yield
N/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/AN/AN/AN/AN/AN/A
Operating Profit Margin
N/AN/AN/AN/AN/AN/AN/A
Pretax Profit Margin
N/AN/AN/AN/AN/AN/AN/A
Net Profit Margin
N/AN/AN/AN/AN/AN/AN/A
Effective Tax Rate
3.86%0.51%-7.31%2.28%N/AN/A-3.65%
Return on Assets
-13.45%-125.72%-29.11%-55.80%-42.47%-27.93%-77.41%
Return On Equity
92.72%81.57%-31.20%-73.34%-58.70%-29.71%-30.45%
Return on Capital Employed
-15.09%-199.53%-26.67%-68.69%-55.55%-100.47%-47.68%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/AN/A5.89N/A
Quick Ratio
26.872.1914.895.874.835.6610.38
Cash ratio
26.862.1914.685.660.375.6610.17
Days of Sales Outstanding
N/AN/AN/AN/AN/AN/AN/A
Days of Inventory outstanding
N/AN/AN/A173.75N/AN/A86.87
Operating Cycle
N/AN/AN/AN/AN/AN/AN/A
Days of Payables Outstanding
N/A885.373.48K1.41K711.02N/A2.44K
Cash Conversion Cycle
N/AN/AN/AN/AN/AN/AN/A
Debt Ratios
Debt Ratio
N/AN/A0.00N/A0.000.230.11
Debt Equity Ratio
N/AN/A0.00N/A0.000.310.15
Long-term Debt to Capitalization
N/AN/AN/AN/AN/A0.10N/A
Total Debt to Capitalization
N/AN/A0.00N/A0.00N/A0.00
Interest Coverage Ratio
N/AN/AN/AN/AN/A-248.07N/A
Cash Flow to Debt Ratio
N/AN/A-214.09N/A-57.39N/A-107.04
Company Equity Multiplier
-6.89-0.641.071.311.381.310.21
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/AN/AN/AN/AN/AN/A
Free Cash Flow / Operating Cash Flow Ratio
11.141.011.071.091.041.08
Cash Flow Coverage Ratio
N/AN/A-214.09N/A-57.39N/A-107.04
Short Term Coverage Ratio
N/AN/A-214.09N/A-57.39N/A-107.04
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/A